Cargando…
In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment
PURPOSE: Colistin resistance in Acinetobacter baumannii (A. baumannii) is mediated by a complete loss of lipopolysaccharide production via mutations in lpxA, lpxC, and lpxD gene or lipid A modifications via mutations in the pmrA and pmrB genes. However, the exact mechanism of therapy-induced colisti...
Autores principales: | Kim, Yoonjung, Bae, Il Kwon, Jeong, Seok Hoon, Yong, Dongeun, Lee, Kyungwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479859/ https://www.ncbi.nlm.nih.gov/pubmed/26069113 http://dx.doi.org/10.3349/ymj.2015.56.4.928 |
Ejemplares similares
-
In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates
por: Lee, Hyukmin, et al.
Publicado: (2016) -
Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens
por: Lee, Kyungwon, et al.
Publicado: (2011) -
Prediction of Putative Resistance Islands in a Carbapenem-Resistant Acinetobacter baumannii Global Clone 2 Clinical Isolate
por: Lee, Yangsoon, et al.
Publicado: (2016) -
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
por: Lee, Chang-Ro, et al.
Publicado: (2017) -
Anti-outer Membrane Vesicle Antibodies Increase Antibiotic Sensitivity of Pan-Drug-Resistant Acinetobacter baumannii
por: Huang, Weiwei, et al.
Publicado: (2019)